logo for NBY

NBY • AMEX

NovaBay Pharmaceuticals, Inc.

$19.16

+ Add to Watchlist

Stock Details

Market Cap 2,414,365,951
Day Change 9.7 (102.54%)
Volume 9,401,329
Avg Volume 1,082,965
Price Range 0.46-19.95

Overview

Country US
Sector Healthcare
Industry Biotechnology
Exchange AMEX

Company Profile

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Financial Overview

52 Week High 19.95
52 Week High Date 2026-01-09
52 Week Low 0.46
52 Week Low Date 2025-04-08
10D Avg Trading Vol 2.10962
YTD Price Return Daily 239.7163
MTD Price Return Daily 239.7163

Cash Flow

TTM/Share -5.2402
Annual/Share -1.0364
Quarterly/Share -1.241

Price-to-Earnings

Annual Ratio 0.6806
Quarterly Ratio 2.8521
TTM

Revenue

3Y Growth 5.12
5Y Growth 8.19
Annual/Share -38.05
TTM/Share 2.8802
5Y Share Growth -23.01

Earnings Per Share

Annual -2.1269
3Y Growth
5Y Growth
Quarterly YOY Growth

Price-to-Book

Ratio 280.8155
Annual Ratio 0.4019
TTM 0.7947